DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Tech
Published
08 Aug 25
Updated
16 Jun 26
Views
72
Not Invested
Evolv Technologies HoldingsEVLV
EVLV logo
Fair Value
US$10.5
Share price16 Jun
US$5.1151.3% undervalued intrinsic discount
Loading
1Y-38.95%
7D0.79%

Urbanization And AI Will Revolutionize Touchless Screening

AN
AnalystHighTarget
AnalystHighTarget

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published
08 Aug 25
Updated
16 Jun 26
Views
72
Not Invested
Fair ValueUS$10.5
Share priceUS$5.11
51.3% undervalued intrinsic discount
Narrative
Updates6

Shared on 16 Jun 26

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Evolv says demand is picking up as more schools, hospitals, and venues roll out its touchless weapons-screening systems, helped by clearer messaging after earlier confusion in reported results. A key government safety designation and a planned manufacturing ramp could improve how much money the company keeps from each sale over time.
Read more
11 viewsusers have viewed this narrative update

Shared on 18 Apr 26

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
Read more
5 viewsusers have viewed this narrative update

Shared on 20 Mar 26

Fair value Increased 5.00%

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
Read more
6 viewsusers have viewed this narrative update

Shared on 06 Mar 26

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).
Read more
5 viewsusers have viewed this narrative update

Shared on 05 Feb 26

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.
Read more
3 viewsusers have viewed this narrative update

Shared on 08 Jan 26

Fair value Increased 21%

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.
Read more
9 viewsusers have viewed this narrative update

Fair Value vs Share Price

US$10.5
vs US$5.1151.3% undervalued intrinsic discount
PastFuture-142m272m2019202120232025202620272029Revenue US$271.8mEarnings US$22.6m
19.3%
Revenue growth
8.3%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Evolv Technologies Holdings

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and slightly overvalued.

Market capUS$934.6m
PB7.8x
Estimated Growth17.4%
Dividend YieldN/A
Full analysis

CEO & management

John Kedzierski
CEO
2.2yrs
CEO Tenure

Develops, manufactures, markets, and sells security screening products and specific services in the United States and internationally.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide